0 results for 'Janssen Pharmaceutical'
Morgan Lewis Lawyer Defends Drugmaker as New Trial Over Opioid Crisis Begins
Three drug companies that won a California bench verdict last year in one of the first opioid trials in the nation went to trial on Monday against West Virginia.
'McKinsey Bargained for Closure.' Consultant Moves to Dismiss Opioid Lawsuits
McKinsey & Co.'s arguments to dismiss opioid lawsuits have garnered amicus support from 11 states, including Connecticut and Texas, and the U.S. Chamber of Commerce and the American Tort Reform Association.
Teva Settles Rhode Island's Opioid Case, Avoiding Trial
Attorney General Peter Neronha announced on Monday that Rhode Island had settled opioid claims against Teva and Allergan for a total value of about $107 million.
Georgia Will Help Decide Who Gets the $2.3B in Legal Fees in the Global Opioid Deal
The fees and costs outlined in the $26 billion opioid deal with Johnson & Johnson's Janssen Pharmaceuticals and three distributors are a mix of common benefit fees, contingency fees and payments to the states for outside counsel. One law professor said, "it's not like the lawyers are going to be impoverished."
Opioid Judge 'Clearly Abused His Discretion,' Appeals Court Says
The U.S. Court of Appeals for the Sixth Circuit on Friday issued a mandate against U.S. District Judge Dan Polster, who is overseeing 3,000 opioid lawsuits in multidistrict litigation, for failing to address hundreds of remand motions pending before him for more than three years.
Who Gets the $2.3 Billion in Legal Fees in the Global Opioid Deal?
The fees and costs outlined in the $26 billion opioid deal with Johnson & Johnson's Janssen Pharmaceuticals and three distributors are a mix of common benefit fees, contingency fees and payments to the states for outside counsel. One law professor said, "it's not like the lawyers are going to be impoverished."
Dividing $2.3 Billion in Legal Fees: Who Gets What in the Global Opioid Deal?
The fees and costs outlined in the $26 billion opioid deal with Johnson & Johnson's Janssen Pharmaceuticals and three distributors are a mix of common benefit fees, contingency fees and payments to the states for outside counsel. One law professor said, "it's not like the lawyers are going to be impoverished."
Del. Among States Vying for Slice of $2.3B in Legal Fees From the Global Opioid Deal
The fees and costs outlined in the $26 billion opioid deal with Johnson & Johnson's Janssen Pharmaceuticals and three distributors are a mix of common benefit fees, contingency fees and payments to the states for outside counsel. One law professor said, "it's not like the lawyers are going to be impoverished."
Federal Judge Upholds First Jury Verdict Over Opioid Crisis
In a pair of orders on Monday, U.S. District Judge Dan Polster, among other findings, upheld his decision to excuse three unvaccinated jurors from the trial, concluding there was "no doubt that trial would have been disrupted."
Judge Upholds First Jury Verdict Over Opioid Crisis
In a pair of orders on Monday, U.S. District Judge Dan Polster, among other findings, upheld his decision to excuse three unvaccinated jurors from the trial, concluding there was "no doubt that trial would have been disrupted."TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Andy Goldberg, Laner Muchin Managing Partner 1 minute read
Resources
Corporate Transparency Act Resource Kit
Brought to you by Wolters Kluwer
Download Now
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now